Conjoined twins from Braidwood successfully separated in New York surgery : abc7chicago

The bacterium that causes meningitis, Neisseria meningitidis, is a very close relative of the species that causes gonorrhoea - Neisseria gonorrhoeae. The importance of preventing people developing a gonorrhoea infection is of mounting importance as the infection is getting much harder to treat. Dr Helen Petousis-Harris, one of the researchers, said: "This is the first time a vaccine has shown any protection against gonorrhoea. Image copyright Getty ImagesA vaccine has for the first time been shown to protect against the sexually transmitted infection gonorrhoea, scientists in New Zealand say. "We are still a long way before we develop a vaccine for gonorrhoea, but we have now some evidence that it is possible."

Effectiveness of a group B outer membrane vesicle meningococcal vaccine against gonorrhoea in New Zealand: a retrospective case-control study

Find out more about The Lancet Choice Simply purchase your Lancet Choice pass from the Summary or Full Text page of an article you wish to access. This will count as the first of 5 article credits, or 'Allowances', and you can use your 4 remaining Allowances to access other articles from any of The Lancet journals. The Lancet Choice is a new payment option that gives you the freedom and flexibility to access any 5 premium articles of your choice from across The Lancet family of journals - all for a one-off payment of $49.00 USD.

First vaccine to protect against gonorrhoea developed

The first vaccination shown to protect against the sexually transmitted infection gonorrhoea has been developed by scientists. The report, published in the Lancet journal, stated: "Exposure to MeNZB was associated with reduced rates of gonorrhoea diagnosis, the first time a vaccine has shown any protection against gonorrhoea. "These results provide a proof of principle that can inform prospective vaccine development not only for gonorrhoea but also for meningococcal vaccines."There were almost 35,000 cases of gonorrhoea reported in England in 2014. The study of New Zealanders aged 15 to 30 found gonorrhoea cases had fallen by 31 per cent in those vaccinated with MeNZB – something originally developed to treat against meningitis. It is the second most common bacterial sexually transmitted infection in the UK after chlamydia, with the majority of cases affecting people under the age of 25.


collected by :Lucy William

To follow all the new news about Health care

Edit This Article